Digbi Health and West Virginia University Enter Research Partnership on Postoperative Weight Loss, Genetics and the Gut Microbiome
The clinical pilot will evaluate Digbi Health's personalized obesity program in bariatric surgery patients one year after sleeve gastrectomy.
MOUNTAIN VIEW, Calif., December 22, 2020 /Digbi Newswire/ -- Digbi Health today announced a research collaboration with West Virginia University Medicine and the WVU Bariatrics Surgical Weight-Loss Program. The study will use Digbi Health's personalized digital therapeutics platform to better understand the role of the gut microbiome and human genetics in postoperative weight loss and maintenance.
The clinical pilot will evaluate the effectiveness of Digbi Health's obesity management program personalized to each bariatric surgery patient one year after sleeve gastrectomy. The program is tuned to the patient's lifestyle, genetics and gut microbiome risks to assist with weight loss and with maintaining a healthy weight.
A long-term solution for obesity
Obesity is a complex metabolic disease and an ongoing global epidemic, associated with inflammatory, digestive, musculoskeletal and skin morbidities. It is a risk factor for diabetes, cardiovascular disease and COVID-19, and can reduce life expectancy.
Bariatric surgery is an effective long-term intervention for morbid obesity. Yet to reap the best outcomes from surgery, patients need to make lifelong changes in eating patterns, and social support is a major factor in making those changes stick.
Research indicates that an individual's genetics and gut microbiome are intrinsically linked to their metabolism. Digbi's personalized meal plans and nutrition guidelines are curated to an individual's genetic and gut microbiome markers, contributing to successful post-operative weight loss and helping with weight maintenance.
Investigator
Nova Szoka, MD, FACS, FASMBS, Assistant Professor at J.W. Ruby Memorial Hospital, WVU Bariatrics Surgical Weight-Loss Center, is the principal investigator of the study.
WVU Bariatrics is excited to partner with Digbi Health to better understand how genomic, gut microbiome, and metabolomic factors can contribute to successful weight loss following bariatric surgery.
— Nova Szoka, MD, FACS, FASMBS, Principal Investigator, WVU Bariatrics Surgical Weight-Loss Center
Originally distributed via PR Newswire.
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE Digbi Health
- Research Partnership
- Obesity
- Bariatric Surgery
- Gut Microbiome
- Genetics